Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taiwan - Delayed Quote TWD

Bora Pharmaceuticals Co., LTD. (6472.TW)

Compare
692.00
-6.00
(-0.86%)
At close: April 2 at 1:30:33 PM GMT+8
Loading Chart for 6472.TW
  • Previous Close 698.00
  • Open 700.00
  • Bid 692.00 x --
  • Ask 693.00 x --
  • Day's Range 681.00 - 700.00
  • 52 Week Range 673.00 - 975.00
  • Volume 823,764
  • Avg. Volume 1,386,121
  • Market Cap (intraday) 71.41B
  • Beta (5Y Monthly) 0.66
  • PE Ratio (TTM) 19.30
  • EPS (TTM) 35.85
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield 12.00 (1.73%)
  • Ex-Dividend Date Aug 12, 2024
  • 1y Target Est 978.67

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services. In addition, it provides food and vitamin supplements, and skincare products; and biotechnical services. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.

www.bora-corp.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6472.TW

View More

Performance Overview: 6472.TW

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6472.TW
7.98%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
7.54%

1-Year Return

6472.TW
1.56%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
4.06%

3-Year Return

6472.TW
9.84%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
20.84%

5-Year Return

6472.TW
9.84%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
120.40%

Compare To: 6472.TW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6472.TW

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    71.41B

  • Enterprise Value

    84.47B

  • Trailing P/E

    19.32

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.03

  • Price/Book (mrq)

    5.55

  • Enterprise Value/Revenue

    4.39

  • Enterprise Value/EBITDA

    13.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.47%

  • Return on Assets (ttm)

    5.98%

  • Return on Equity (ttm)

    30.18%

  • Revenue (ttm)

    19.25B

  • Net Income Avi to Common (ttm)

    3.94B

  • Diluted EPS (ttm)

    35.85

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.92B

  • Total Debt/Equity (mrq)

    126.39%

  • Levered Free Cash Flow (ttm)

    -4.97B

Research Analysis: 6472.TW

View More

Company Insights: 6472.TW

Research Reports: 6472.TW

View More

People Also Watch